SAGITTARIUS presented at the ASCO Annual Meeting 2025

Chicago and online, May 30-June 3, 2025

The SAGITTARIUS clinical trial was presented with a dedicated poster at the ASCO Annual Meeting 2025, held from May 31 to June 4 at McCormick Place in Chicago and online. The event, held annually by the American Society of Clinical Oncology, is one of the world’s most prestigious conferences in oncology, bringing together tens of thousands of oncology professionals from around the globe to share the latest advances in cancer research and treatment.

SAGITTARIUS was featured in the Gastrointestinal Cancer—Colorectal and Anal poster session with a poster (Abstract TPS3647) titled: “A precision medicine trial leveraging tissue and blood-based tumor genomics to optimize treatment in resected stage III and high-risk stage II colon cancer (CC) patients (pts): The SAGITTARIUS trial”, highlighting its innovative approach to personalized treatment for colon cancer patients.

Several SAGITTARIUS experts contributed to the poster, including representatives from several participating centers in Italy, Spain, and Germany, such as the Study Chair Dr. Clara Montagut (Hospital del Mar Research Institute, Barcelona, Spain) and the Scientific Coordinator Dr. Silvia Marsoni (IFOM ETS, Milan, Italy). The poster was presented by Dr. Stefano Tamberi, Principal Investigator for the SAGITTARIUS clinical trial at the Azienda Unità Sanitaria Locale della Romagna (Italy), one of the centres of the SAGITTARIUS clinical network.

SAGITTARIUS’s presence at ASCO marked an important milestone in the dissemination of the project’s goals and methodology to the international oncology community.

To learn more about the SAGITTARIUS trial and its objectives, watch the video here.

Download and read the poster here.